Actively Recruiting

All Genders
NCT07147465

Performance Indicators and Impact on the Care Pathway of Sequencing on the SeqOIA and AURAGEN (Seqogen) Platforms for Oncology Patients

Led by Assistance Publique - Hôpitaux de Paris · Updated on 2025-08-29

3149

Participants Needed

3

Research Sites

65 weeks

Total Duration

On this page

Sponsors

A

Assistance Publique - Hôpitaux de Paris

Lead Sponsor

A

AuraGen Aesthetics LLC

Collaborating Sponsor

AI-Summary

What this Trial Is About

As part of the French Genomic Medicine Plan 2025 (FGM), the SeqOIA and AURAGEN platforms were selected to perform high-throughput genomic sequencing. The SONCO (Sequencing Oncology Cohort) project combines their medical and economic evaluations into a single national cohort. Its objective is to assess the impact of genomic sequencing on care pathways and treatment recommendations by collecting indicators related to quality, turnaround time, and patient information. Clinical data are gathered from molecular tumor board reports (via SPICE and HYGEN) and from hospital medical records. This cohort is intended to support public health decision-making and help anticipate the organization of future genomic platforms.

CONDITIONS

Official Title

Performance Indicators and Impact on the Care Pathway of Sequencing on the SeqOIA and AURAGEN (Seqogen) Platforms for Oncology Patients

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients diagnosed with cancer and referred for high-throughput sequencing
  • Patients with sequencing pre-indication validated by the upstream multidisciplinary tumor board since January 1, 2021
  • Patients who have agreed to the reuse of their medical and genomic data for research purposes and have not opposed this use
Not Eligible

You will not qualify if you...

  • Patients who oppose the reuse of their medical and genomic data
  • Patients without validated sequencing pre-indication by the upstream multidisciplinary tumor board

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 3 locations

1

Centre Leon Berard

Lyon, France, 69000

Actively Recruiting

2

APHP Hôtel Dieu URC Economie de la sante /URC ECO

Paris, France, 75004

Active, Not Recruiting

3

HOPITAL AP-HP Cochin

Paris, France, 75005

Actively Recruiting

Loading map...

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here